Professor Saskia Middeldorp presented the result of the Highlow Study at the recent ISTH 2022 congress in London, which investigated the different dosages of low molecular weight heparins in pregnant pregnant and postpartum women with a history of venous thromboembolism.

Video: https://congressreport.eu/scientific-contents/interview:ten-months-needles-wed-better-get-it-right-highlow-study

We asked Professor Sam Schulman about the ISTH Guidelines on antithrombotic treatment in COVID-19.

Video: https://congressreport.eu/scientific-contents/interview:isth-guidelines-anticoagulation-covid-19

We asked Professor Mark R. Payne about the new results of the SAXOPHONE Study what he presented at the recent ISTH 2022 congress. The study  investigated the use of apixaban in children with heart disease. (A Multi-Center, Multi-National Randomized Trial of Apixaban versus Standard of Care Anticoagulation for Thromboprophylaxis in Children with Congenital or Acquired Heart Disease)

Video: https://congressreport.eu/scientific-contents/interview:saxophone-study

DOACs revolutionize the anticoagulation treatment in the last decade, but we have a few open question yet. We asked Professor James Douketis about the optimal perioperative management with regards to safety and efficacy.

Video: https://congressreport.eu/scientific-contents/interview:current-guidelines-perioperative-anticoagulation-management-doacs

Professor Jan Václavík held a lecture at the recent European Society of Hypertension 2022 Congress about the diagnosis of non-adherence in antihypertensive treatment.

Video: https://congressreport.eu/scientific-contents/interview:diagnosis-non-adherence-clinical-consultation

Professor Alberico L. Catapano spoke about the European Atherosclerosis Society annual meeting, the novelties presented there, the ESC/EAS joint session discussing the new dyslipidemia guideline.

Video: https://congressreport.eu/scientific-contents/interview:esceas-joint-session-deep-dive-prevention-gls-focus-dyslipidemia

At the recent European Society of Hypertension 2022 annual congress, nocturnal hypertension addressed as one of the six hot questions in blood pressure monitoring. Professor Paolo Palatini shared his insights with us on nocturnal hypertension. 

Video: https://congressreport.eu/scientific-contents/interview:nocturnal-hypertension

There are long standing debates around the blood pressure lowering treatment in elderly patients.  Fortunately more and more clinical trials includes older populations. The emerging data has been discussed during the interesting session of the recent European Society of Hypertension 2022 annual congress in Athens. We asked Professor Athanase Benetos who chaired the session to share the key massefges to the audience.

Video: https://congressreport.eu/scientific-contents/interview:blood-pressure-management-older-frail-patients

Professor Giuseppe Mancia spoke about a very interesting session from the recent European Society of Hypertension congress in Athens. The session was about the lifelong burden of hypertension, he talked about vascular aging and other interesting concepts which could put risk charts and risks course into a new perspective.

Video: https://congressreport.eu/scientific-contents/interview:lifelong-burden-hypertension

Professor Ana Giménez-Arnau chaired a very interesting session about chronic urticaria and the new pathogenic insights about it at the recent EADV symposium in Ljubljana.

Video: https://congressreport.eu/scientific-contents/interview:new-pathogenic-insights-chronic-urticaria